December 2018 FDA Recall Absorica Ld by Sun Pharmaceutical Industries, Inc.
D-1207-2019 - Subpotent Drug

This Class III drug recall was voluntarily initiated by Sun Pharmaceutical Industries, Inc. on December 7, 2018 for the product Absorica Ld. The FDA reported the reason for recall as subpotent drug. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1207-2019

Reason for Recall
Subpotent Drug: Isotretinoin content results were lower than the specification limit obtained during routing product monitoring.
Initiated
12-07-2018
Reported
12-26-2018
Quantity
47,520 prescription packs

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Sun Pharmaceutical Industries, Inc.
Nationwide in the USA
Absorica (Isotretinoin) Capsules 30 mg USP, 30 capsules (3x10 Prescription Packs) Rx only, Manufactured by: Galephar Pharmaceutical Research Inc. Humacao, PR 00792, Distributed by: Sun Pharmaceutical Industries Inc. Cranbury, NJ 08512, UPC 310631117313, NDC 10631-117-31 (carton) NDC10631-117-69 (prescription pack)

Batch or Lot Expiration Information

Lot# Lot: 17F28AA, Exp 1/2020